Prospective, longitudinal analysis of the gut microbiome in patients with locally advanced rectal cancer predicts response to neoadjuvant concurrent chemoradiotherapy

Keyphrases

• Gut Microbiome 100%
• Response Predictors 100%
• Prospective Longitudinal Study 100%
• Longitudinal Analysis 100%
• Locally Advanced Rectal Cancer 100%
• Neoadjuvant Concurrent Chemoradiotherapy 100%
• Immunomodulatory Protein 25%
• Luminex 16%
• Poor Outcome 8%
• Longitudinal Change 8%
• Immune Cells 8%
• Radiotherapy 8%
• Sectional Analysis 8%
• Host Immune Response 8%
• Mucosal Immunity 8%
• Blood Samples 8%
• Individualized Treatment 8%
• Microbial Composition 8%
• Peripheral Blood 8%
• Blood Levels 8%
• Systemic Immune Response 8%
• Area under the Receiver Operating Characteristic Curve 8%
• Best Response 8%
• Immunomodulator 8%
• Area Under the Precision-Recall Curve 8%
• Gut Microbiota 8%
• Lymphocyte Count 8%
• Poor Response 8%
• Early Prediction 8%
• Cell Wall Proteins 8%
• Fecal Samples 8%
• Characteristic Variation 8%
• Multivariate Association 8%
• 16S rRNA Sequencing 8%
• Microbial Profile 8%
• Herpesvirus Entry Mediator 8%
• Canonical Correspondence Analysis 8%
• Sparse Partial Least Squares Regression 8%
• Microbial Community Structure 8%
• Microbial Taxa 8%
• Millipore 8%
• Longitudinal Variation 8%
• Clostridium Sensu Stricto 8%
• Intestinimonas 8%
• Enterotype 8%

Immunology and Microbiology

• Gut Microbiome 100%
• Immunocompetent Cell 50%
• Taxon 50%
• Blood Level 25%
• Mucosal Immunity 25%
• Mediator 25%
• Herpesviridae 25%
• Clostridium 25%
• Immune System 25%
• Immunomodulating Drugs 25%
• Intestine Flora 25%
• Lymphocyte Count 25%
• Enterotype 25%